|Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer.|
CL Bennett, MR Ferreira, TC Davis, J Kaplan, M Weinberger, T Kuzel, ...
Journal of Clinical Oncology 16 (9), 3101-3104, 1998
|Repurposing metformin for cancer treatment: current clinical studies|
YK Chae, A Arya, MK Malecek, DS Shin, B Carneiro, S Chandra, J Kaplan, ...
Oncotarget 7 (26), 40767, 2016
|Wnt/beta-catenin pathway: modulating anticancer immune response|
SG Pai, BA Carneiro, JM Mota, R Costa, CA Leite, R Barroso-Sousa, ...
Journal of hematology & oncology 10 (1), 101, 2017
|Genomic landscape of DNA repair genes in cancer|
YK Chae, JF Anker, BA Carneiro, S Chandra, J Kaplan, A Kalyan, ...
Oncotarget 7 (17), 23312, 2016
|Outcomes of patients with double-hit lymphoma who achieve first complete remission|
DJ Landsburg, MK Falkiewicz, J Maly, KA Blum, C Howlett, T Feldman, ...
Journal of Clinical Oncology 35 (20), 2260, 2017
|Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA|
YK Chae, AA Davis, BA Carneiro, S Chandra, N Mohindra, A Kalyan, ...
Oncotarget 7 (40), 65364, 2016
|Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling|
YK Chae, SY Chung, AA Davis, BA Carneiro, S Chandra, J Kaplan, ...
Oncotarget 6 (35), 37117, 2015
|Exchange versus simple transfusion for acute chest syndrome in sickle cell anemia adults|
JM Turner, JB Kaplan, HW Cohen, HH Billett
Transfusion 49 (5), 863-868, 2009
|Statins as anti-cancer therapy; Can we translate preclinical and epidemiologic data into clinical benefit?|
YK Chae, M Yousaf, MK Malecek, B Carneiro, S Chandra, J Kaplan, ...
Discovery medicine 20 (112), 413-427, 2015
|Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives|
R Costa, BA Carneiro, S Chandra, SG Pai, YK Chae, JB Kaplan, ...
Drug design, development and therapy 10, 873, 2016
|Blinatumomab for the treatment of acute lymphoblastic leukemia|
JB Kaplan, M Grischenko, FJ Giles
Investigational new drugs 33 (6), 1271-1279, 2015
|Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia|
BA Carneiro, JB Kaplan, JK Altman, FJ Giles, LC Platanias
Cancer biology & therapy 16 (5), 648-656, 2015
|Progression of undiagnosed cutaneous lymphoma after anti–tumor necrosis factor-alpha therapy|
ME Martinez-Escala, AL Posligua, H Wickless, A Rutherford, KA Sable, ...
Journal of the American Academy of Dermatology 78 (6), 1068-1076, 2018
|Nodal signaling as a developmental therapeutics target in oncology|
A Kalyan, BA Carneiro, S Chandra, J Kaplan, YK Chae, M Matsangou, ...
Molecular cancer therapeutics 16 (5), 787-792, 2017
|CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder|
ME Martinez-Escala, RW Kantor, A Cices, XA Zhou, JB Kaplan, B Pro, ...
Journal of the American Academy of Dermatology 77 (3), 489-496, 2017
|Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia|
KM McMahon, C Scielzo, NL Angeloni, E Deiss-Yehiely, L Scarfo, ...
Oncotarget 8 (7), 11219, 2017
|Tyrosine kinase inhibitor therapy in chronic myeloid leukemia: update on key adverse events|
BA Carneiro, JB Kaplan, FJ Giles
Expert Review of Hematology 8 (4), 457-479, 2015
|Survival outcomes of younger patients with mantle cell lymphoma treated in the rituximab era|
JN Gerson, E Handorf, D Villa, AS Gerrie, P Chapani, S Li, LJ Medeiros, ...
Journal of Clinical Oncology 37 (6), 471-480, 2019
|The challenge of developmental therapeutics for adrenocortical carcinoma|
R Costa, BA Carneiro, F Tavora, SG Pai, JB Kaplan, YK Chae, S Chandra, ...
Oncotarget 7 (29), 46734, 2016
|Durable responses with maintenance dose-sparing regimens of romidepsin in cutaneous T-cell lymphoma|
ME Martinez-Escala, TM Kuzel, JB Kaplan, A Petrich, B Nardone, ...
Jama Oncology 2 (6), 790-793, 2016